|
InnoCare, which already has three approved therapies, describes itself as a biopharma focusing on cancer and autoimmune disease treatments.
|
 |
|
Roche joins Sanofi on the list of big pharma companies that are betting on Earendil’s AI-powered drug discovery platform.
|
|
|
The decision was supported by Lilly’s QWINT Phase III clinical programme.
|
|
|
Amid this probe, experts point to the importance of airtight AI governance when implementing the technology in high-risk contexts.
|
|
|
Amberstone is eligible for up to $440m in development, regulatory and sales milestones for each target, with royalties.
|
|
